MRZM
MARIZYME INC by Marizyme, Inc. (MRZM)
$
00About MARIZYME INC by Marizyme, Inc. (MRZM)
Marizyme, Inc. is a medical technology company, which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.00
Market cap
39,500
Dividend yield
0.00%
Volume
--
Avg. volume
85
P/E ratio
.00
MARIZYME INC by Marizyme, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.12
52 Week Low
$0.00
Market cap
39,500
Dividend yield
0.00%
Volume
--
Avg. volume
85
P/E ratio
.00